Method for screening drug and chemical effects in laboratory rats using computerized quantitative electroencephalography

Veterinary and Human Toxicology

Volumn 38, Issue 1, 1996, Pages 1-7

  Jones, Randy D ^a   Sheets, Larry P ^a   Mueller, Robert E ^a  

^a BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; MUSCARINIC AGENT; OXOTREMORINE; PHYSOSTIGMINE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BLOOD; BRAIN; DOSE RESPONSE; DRUG EFFECT; DRUG SCREENING; ELECTROENCEPHALOGRAPHY; ENZYMOLOGY; ERYTHROCYTE; FEMALE; FISCHER 344 RAT; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METHODOLOGY; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT;

ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELECTROENCEPHALOGRAPHY; ERYTHROCYTES; FEMALE; INJECTIONS, INTRAPERITONEAL; MALE; MUSCARINIC AGONISTS; OXOTREMORINE; PHYSOSTIGMINE; RANDOM ALLOCATION; RATS; RATS, INBRED F344; RATS, SPRAGUE-DAWLEY;

EID: 0030088070     PISSN: 01456296     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jones RD, Greufe NP: A quantitative electroencephalographic method for xenobiotic screening in the canine model. Journ Pharmacol Toxicol Meth 31: 223-238, 1994.
2. Jones RD, Dass PD: Quantitative electroencephalography and cholinesterase pharmacodynamic response in the dog and miniature pig models given physostigmine. Under Review, 1994.
3. Kemali D, Galderisi S, Maj M et al: Computerized EEC topography findings in schizophrenic patients before and after haloperidol treatment. Int J Psychophysiol 13: 283-290, 1992.
4. Jonkman EJ, Poortvliet DCJ, de Weerd AW et al: Some aspects of the application of qEEG to clinical studies. In Samson-Dollfus D, Guieu JD, Gotman J et al eds: Statistics and Topography in Quantitative EEC. Elsevier, Oxford: 225-236, 1988.
5. Gruzelier JH, Liddiard DH, Wilson L et al: Validation of EEC topographical mapping with neuropsychological tests. In Samson-Dollfus D, Guieu JD, Gotman J et al eds: Statistics and Topography in Quantitative EEC. Elsevier, Oxford: 110-118, 1988.
6. Pagel JF: Modeling drug actions on electrophysiologic effects produced fay EEG modulated potentials. Human Psychopharmacol 8: 211-216, 1993.
7. Lipman JJ, Tolchard S: Separate and combined effects of morphine and amphetamine on quantitative electroencephalogram and regional cerebral glucose uptake in a rat model. Neuropsychobiol 23: 89-98, 1990.
8. Santucci V, Rocher D, Veyrun J et al: Quantitative electroencephalographic profile of 3-(4-hydroxy-1-piperidinyl)-6-(2,4-dichlorophenyl)-pyridazine (SR 41378) in the rat. Naunyn-Schniedebergs Arch Pharmacol 333: 186-189, 1986.
9. Ray DE: Electroencephalographic and evoked response correlates of trimethyltin induced neuronal damage in the rat hippocampus. Journ Appl Toxicol 1: 145-148, 1981.
10. Jones RD: Effects of atropine in the Beagle dog measured by quantitative electroencephalography and regional cortical analysis. Vet Human Toxicol 36: 418-423, 1994.
11. Tomas T, Gralewicz S: A comparison of changes in spontaneous (EEC) and evoked brain activity induced by chlorphenvinphos and physostigmine in rats and rabbits. Polish Journ Occupational Med Environ Health 5: 55-69, 1992.
12. Riekkinen P, Jakala P, Sirvio J et al: The effects of THA on scopolamine and nucleus basalis lesion-induced EEC slowing. Brain Res Bull 26: 633, 1992.
13. Heck WH: Selective adjustment of the speed of internal clock and memory processes. J Exp Psychol (Anim Behav) 9: 171-201, 1983.
14. Warburton DM, Brown K: The facilitation of discrimination performance by physostigmine sulphate. Psychopharmacologia 27: 275-284, 1972.
15. Shurtleff D, Raslear TG, Cenovese RF et al: Perceptual bisection in rats: The effects of physostigmine, scopolamine and pirenzepine. Physiol Behav 51: 381-390, 1992.
16. 2 muscarinic acetylcholine receptor subtypes in the developing cat visual cortex. Dev Brain Res 56: 1-12, 1990.
17. 2 muscarinic receptors in the rat brain. Neuroscience 19: 551-554, 1986.
18. Levey Al, Kitt CA, Simonds WF et al: Identification and localization of muscarinic acetylcholine receptor protein in brain with subtype-specific antibodies. J Neurosci 11: 3218-3226, 1991.
19. Riekkinen P, Riekkinen M, Fisher A et al : Effects of muscarinic receptor agonists and antichol inesterase drugs on high voltage spindles and slow waves. Eur J Pharmacol 240: 1-7, 1993.
20. Bowen DM, Smith CB, White P et al: Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459, m 1976.
21. Ellman GL, Courtney KD, Andres V Jr et al: A new rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88, 1961.
22. Buck WB, Osweiler GD, Van Gelder GA eds: Organophosphorus and carbamate insecticides. In Clinical and Diagnostic Veterinary Toxicology. Kendall/Hunt Publishing Company, Dubuque, IA: 205-225, 1982.
23. Cenovese RF: Effects of azaprophen, scopolamine, and trihexy-phenidyl on schedule-controlled behavior, before and after chronic physostigmine. Eur J Pharmacol 176: 271-279, 1990.
24. Penetar DM: The effects of atropine, benactyzine, and physostigmine on repeated acquisition baseline in monkeys. Psychotrihexy pharmacology (Berlin) 87: 69-76, 1985.
25. Bymaster FP, Heath I, Hendrix JC et al: Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. J Pharmacol Exp Therapeutics 267: 16-24, 1993.